|
"peng cheng yuan"的相關文件
顯示項目 51-71 / 71 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2015 |
Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy
|
Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
| 國立成功大學 |
2014-11-01 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
Manns, Michael; Pol, Stanislas; Jacobson, Ira M.; Marcellin, Patrick; Gordon, Stuart C.; Peng, Cheng-Yuan; Chang, Ting-Tsung; Everson, Gregory T.; Heo, Jeong; Gerken, Guido; Yoffe, Boris; Towner, William J.; Bourliere, Marc; Metivier, Sophie; Chu, Chi-Jen; Sievert, William; Bronowicki, Jean-Pierre; Thabut, Dominique; Lee, Youn-Jae; Kao, Jia-Horng; McPhee, Fiona; Kopit, Justin; Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺北醫學大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng |
| 國立臺灣大學 |
2014 |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naive Taiwanese patients with chronic hepatitis B
|
Chien, Rong-Nan; Peng, Cheng-Yuan; Kao, Jia-Horng; Hu, Tsung-Hui; Lin, Chun-Che; Hu, Chi-Tan; Chen, Chi-Yi; Hsieh, Tsai-Yuan; Lin, Han-Chieh; Chuang, Wan-Long; 高嘉宏 |
| 國立臺灣大學 |
2014 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer; 胡瑞恒; 劉俊人; 陳培哲; 李伯皇; 何明志 |
| 國立臺灣大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺北護理健康大學 |
2013-06 |
Gallstones, a cholecystectomy, chronic pancreatitis, and the risk of subsequent pancreatic cancer in diabetic patients: a population- based cohort study
|
Lai, Hsueh-Chou;Tsai, I-Ju;Chen, Pei-Chun;Muo, Chih-Hsin;Chou, Jen-Wei;Peng, Cheng-Yuan;Lai, Shih-Wei;Sung, Fung-Chang;Lyu, Shu-Yu;Donald, E.Morisky |
| 慈濟大學 |
2013 |
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
|
Wang, Chia?Chi;Tseng, Kuo?Chih;Peng, Cheng?Yuan;Hsieh, Tsai?Yuan;Lin, Chih?Lin;Su, Tung?Hung;Tseng, Tai?Chung;Hsu, Ching?Sheng;Lin, Hans Hsienhong;Kao, Jia?Horng |
| 國立臺灣大學 |
2013 |
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2013 |
Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir
|
Wang, Chia-Chi; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Hsieh, Tsai-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Hsu, Ching-Sheng; Lin, Hans Hsienhong; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2013 |
Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients
|
Yuan, Quan; Song, Liu-Wei; Liu, Chun-Jen; Li, Zhuo; Liu, Ping-Guo; Huang, Cheng-Hao; Yan, Yan; Ge, Sheng-Xiang; Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao; 陳定信; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2013 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立成功大學 |
2012-12 |
Peginterferon Lambda, a New Potential Therapeutic Option for the Treatment of Chronic Hepatitis B: A Phase 2B Comparison with Peginterferon Alfa in Patients with HBeAg-Positive Disease
|
Chan, Henry Lik-Yuen; Ahn, Sang Hoon; Chang, Ting-Tsung; Peng, Cheng-Yuan; Wong, David K.; Coffin, Carla S.; Lim, Seng Gee; Chen, Pei-Jer; Janssen, Harry L.; Marcellin, Patrick; Serfaty, Lawrence; Zeuzem, Stefan; Hu, Wenhua; Critelli, Linda; Lopez-Talavera, Juan Carlos; Cooney, Elizabeth L. |
| 淡江大學 |
2012 |
臺灣液晶螢幕逆物流分析與其回收再製品市場區隔研究
|
彭成源; Peng, Cheng-Yuan |
| 國立臺灣大學 |
2012 |
Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立成功大學 |
2009-05 |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu, Chun-Jen; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Pin-Wen; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Lee, Ching-Chih; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 亞洲大學 |
2009-02 |
Th1 and Th2 cytokines are elevated in HCV-infected SVR( ) patients treated with interferon-alpha
|
萬磊;Wan, Lei;Kung, Yung-Jen;Lin, Ying-Ju;Liao, Chiu-Chu;Jim, J.C.Sheu;Tsai, Yuhsin;Lai, Hsueh-Chou;Peng, Cheng-Yuan;Tsai, Fuu-Jen |
| 國立臺灣大學 |
2006 |
Enhanced nuclear factor-kappa B-associated Wnt-1 expression in hepatitis B- and C-related hepatocarcinogenesis: identification by functional proteomics
|
Lee, Tzong-Hsien; Tai, Dar-In; Cheng, Cha-Ju; Sun, Chi-Shu; Lin, Ching-Yih; Sheu, Ming-Jen; Lee, Wei-Ping; Peng, Cheng-Yuan; Wang, Andrew H.-J.; Tsai, Sun-Lung |
| 亞洲大學 |
2005-12 |
新整合課程：分年、分段、分組教改之經驗及學生評論回饋分析
|
Chen,Walter;Shen,Wu-Chung;Hung,Jui-Sung;Peng,Cheng-Yuan;Lin,Kuo-Juei;Lin,Chouh-Jiuan;Wu,His-Chin;Chao-Tien Hsu;Cheng-Chieh Lin;Chang-Hai Tsai |
| 臺北醫學大學 |
1991 |
維生素A之定量分析及對大白鼠體內脂質代謝的影響
|
彭政元; PENG, CHENG-YUAN |
顯示項目 51-71 / 71 (共2頁)
<< < 1 2
每頁顯示[10|25|50]項目
|
